Freestone Capital Holdings’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $830K | Buy |
5,436
+339
| +7% | +$52K | 0.03% | 264 |
|
|
2025
Q4 | $703K | Buy |
5,097
+1,834
| +56% | +$240K | 0.02% | 290 |
|
|
2025
Q3 | $418K | Sell |
3,263
-5
| -0.2% | -$610 | 0.01% | 378 |
|
|
2025
Q2 | $395K | Sell |
3,268
-216
| -6% | -$24.3K | 0.01% | 329 |
|
|
2025
Q1 | $388K | Sell |
3,484
-266
| -7% | -$28.3K | 0.01% | 314 |
|
|
2024
Q4 | $365K | Sell |
3,750
-210
| -5% | -$22.4K | 0.01% | 324 |
|
|
2024
Q3 | $455K | Sell |
3,960
-80
| -2% | -$9.08K | 0.02% | 306 |
|
|
2024
Q2 | $430K | Sell |
4,040
-348
| -8% | -$34.9K | 0.02% | 321 |
|
|
2024
Q1 | $424K | Sell |
4,388
-161
| -4% | -$16.5K | 0.02% | 323 |
|
|
2023
Q4 | $459K | Sell |
4,549
-190
| -4% | -$18.3K | 0.02% | 284 |
|
|
2023
Q3 | $483K | Sell |
4,739
-2,546
| -35% | -$258K | 0.03% | 245 |
|
|
2023
Q2 | $735K | Sell |
7,285
-1,757
| -19% | -$176K | 0.03% | 225 |
|
|
2023
Q1 | $832K | Sell |
9,042
-560
| -6% | -$48.9K | 0.04% | 212 |
|
|
2022
Q4 | $871K | Sell |
9,602
-11,470
| -54% | -$966K | 0.04% | 208 |
|
|
2022
Q3 | $1.6M | Sell |
21,072
-15,655
| -43% | -$1.3M | 0.07% | 162 |
|
|
2022
Q2 | $3.1M | Sell |
36,727
-46,229
| -56% | -$4.06M | 0.12% | 120 |
|
|
2022
Q1 | $7.28M | Buy |
82,956
+10,834
| +15% | +$938K | 0.29% | 76 |
|
|
2021
Q4 | $6.31M | Sell |
72,122
-170
| -0.2% | -$14.1K | 0.27% | 79 |
|
|
2021
Q3 | $5.91M | Sell |
72,292
-7,739
| -10% | -$696K | 0.3% | 81 |
|
|
2021
Q2 | $7.3M | Sell |
80,031
-2,548
| -3% | -$227K | 0.37% | 69 |
|
|
2021
Q1 | $7.06M | Buy |
82,579
+24,947
| +43% | +$2.24M | 0.38% | 68 |
|
|
2020
Q4 | $5.44M | Sell |
57,632
-14,034
| -20% | -$1.23M | 0.32% | 75 |
|
|
2020
Q3 | $6.23M | Sell |
71,666
-1,319
| -2% | -$114K | 0.41% | 58 |
|
|
2020
Q2 | $6.38K | Buy |
72,985
+4,841
| +7% | +$418K | 0.07% | 62 |
|
|
2020
Q1 | $5.62K | Buy |
68,144
+25,941
| +61% | +$2.31M | 0.12% | 60 |
|
|
2019
Q4 | $4K | Buy |
42,203
+4,540
| +12% | +$407K | 0.08% | 111 |
|
|
2019
Q3 | $3.27K | Buy |
37,663
+1,640
| +5% | +$147K | 0.08% | 128 |
|
|
2019
Q2 | $3.29K | Buy |
36,023
+3,303
| +10% | +$280K | 0.08% | 127 |
|
|
2019
Q1 | $2.82M | Buy |
32,720
+5,763
| +21% | +$463K | 0.17% | 142 |
|
|
2018
Q4 | $2.07M | Buy |
26,957
+8,204
| +44% | +$639K | 0.14% | 159 |
|
|
2018
Q3 | $1.45M | Buy |
18,753
+2,756
| +17% | +$204K | 0.01% | 186 |
|
|
2018
Q2 | $1.08M | Buy |
15,997
+2,188
| +16% | +$151K | 0.01% | 217 |
|
|
2018
Q1 | $1M | Buy |
13,809
+280
| +2% | +$21.3K | 0.06% | 220 |
|
|
2017
Q4 | $1.02M | Buy |
13,529
+1,076
| +9% | +$81.2K | 0.07% | 214 |
|
|
2017
Q3 | $958K | Buy |
12,453
+603
| +5% | +$45.5K | 0.07% | 211 |
|
|
2017
Q2 | $886K | Buy |
11,850
+693
| +6% | +$49.1K | 0.07% | 204 |
|
|
2017
Q1 | $742K | Sell |
11,157
-198
| -2% | -$13.2K | 0.06% | 223 |
|
|
2016
Q4 | $741K | Sell |
11,355
-6,854
| -38% | -$445K | 0.06% | 219 |
|
|
2016
Q3 | $1.29M | Sell |
18,209
-574
| -3% | -$41.8K | 0.12% | 153 |
|
|
2016
Q2 | $1.39M | Sell |
18,783
-884
| -4% | -$61.1K | 0.14% | 142 |
|
|
2016
Q1 | $1.28M | Sell |
19,667
-4,227
| -18% | -$288K | 0.13% | 139 |
|
|
2015
Q4 | $1.84M | Buy |
23,894
+7,122
| +42% | +$566K | 0.19% | 78 |
|
|
2015
Q3 | $1.38M | Buy |
16,772
+2,023
| +14% | +$180K | 0.15% | 123 |
|
|
2015
Q2 | $1.3M | Sell |
14,749
-2,442
| -14% | -$224K | 0.21% | 77 |
|
|
2015
Q1 | $1.52M | Sell |
17,191
-13,309
| -44% | -$1.18M | 0.24% | 61 |
|
|
2014
Q4 | $2.53M | Buy |
30,500
+109
| +0.4% | +$9.04K | 0.42% | 36 |
|
|
2014
Q3 | $2.56M | Sell |
30,391
-1,541
| -5% | -$125K | 0.44% | 39 |
|
|
2014
Q2 | $2.59M | Sell |
31,932
-2,657
| -8% | -$209K | 0.4% | 47 |
|
|
2014
Q1 | $2.63M | Sell |
34,589
-10,225
| -23% | -$745K | 0.47% | 37 |
|
|
2013
Q4 | $3.23M | Buy |
44,814
+262
| +0.6% | +$18.2K | 0.57% | 34 |
|
|
2013
Q3 | $3.06M | Buy |
44,552
+2,161
| +5% | +$143K | 0.55% | 32 |
|
|
2013
Q2 | $2.69M | Buy |
+42,391
| New | +$2.76M | 0.55% | 37 |
|
Other funds holding NVS
Freestone Capital Holdings's NVS Position: Q1 2026 in Review
Freestone Capital Holdings increased its Novartis (NVS) stake by 6.7% in Q1 2026, buying an estimated $52K and bringing the position to 5,436 shares worth $830K. The position accounts for 0.03% of the portfolio, ranked #264.
Freestone Capital Holdings first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.3M in Q2 2021. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Freestone Capital Holdings held 5,436 shares of Novartis worth $830K as of Q1 2026.
- Freestone Capital Holdings bought 339 Novartis shares in Q1 2026, an estimated $52K.
- Novartis made up 0.03% of Freestone Capital Holdings's portfolio in Q1 2026, its #264 holding.
- Freestone Capital Holdings first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
- Freestone Capital Holdings's Novartis position peaked at $7.3M in Q2 2021.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Freestone Capital Holdings's 13F filing for Q1 2026, filed 13 May 2026.